cerrar
Tagged with Research

Yeul-Hong Kim – Director, K-MASTER, South Korea
Yeul-Hong Kim, Director of K-MASTER details the project’s success in creating a shared database of genomic data for Korean oncology professionals.…

Emmanuel Hanon – Senior VP, Vaccines R&D, GSK
In an exclusive interview, GSK’s Senior VP for Vaccines R&D Dr Emmanuel Hanon discusses how the sharing of GSK’s adjuvant technology with a…

Brett Monia – CEO, Ionis Pharmaceuticals
Dr Brett Monia, co-founder and CEO of RNA therapeutics pioneer Ionis Pharmaceuticals, outlines the company’s extremely promising development…

BIO 2020: How COVID-19 Will Radically Alter Global Biomedical…
The BIO International Convention was held digitally in June 2020, bringing together over 7,000 participants from around the world. In an…

Constanza Losada – President & CEO, Pfizer Mexico
Recently appointed CEO and president for Pfizer Mexico, Constanza Losada, outlines the exciting challenge of taking on leadership for such an…

Peking University’s Potential COVID-19 Cure
Highly potent neutralizing antibodies may be the key to laying a foundation for COVID-19 treatment, according to a Chinese research team led by Peking…

Pfizer’s COVID-19 Vaccine: A Unique Approach
At the 28 May 2020 IFPMA media briefing on COVID-19 vaccines, Pfizer chairman and CEO Dr Albert Bourla outlined why the US firm had decided to take a…

Nathalie Moll – Director General, European Federation of…
The EFPIA’s Nathalie Moll gives an insight into the work underway across the European pharmaceutical industry to battle COVID-19 in terms of…

Bae Byuongjun – President, KoNECT, South Korea
Dr Bae Byuongjun, president of the Korea National Enterprise for Clinical Trials (KoNECT), outlines why Korea stands out in the APAC region as a top…

Top MSD & Sandoz Execs on the Reality of COVID-19 R&D…
During the 30 April IFPMA virtual media briefing on COVID-19 treatments, key global executives pushed beyond catchy headlines to discuss the current…

Desmond Hau – CEO, Pangenia Group
Dr Desmond Hau, CEO of Pangenia Inc, sits down with PharmaBoardroom to shed light on the company’s progress since taking the reins three years ago.…

Speeding up the Search for Safe & Effective COVID-19…
IFPMA Director General Thomas B. Cueni shares the outcomes of a recent high level pharma industry media briefing on the search for a COVID-19…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here